Our technology enables us to create native-like micro-architecture of the bone tissue with surpassing accuracy on the details.
Printivo is providing pharmaceutical companies with bone tissue graft on demand that can be used for drug testing in pre-clinical trials.
Our Bone tissue model we can easily represent the dimensional complexity of a native human tissue and cell-to-cell interactions.
As a supplementary to the animal models (and replacing them all in future), our Bone graft can provide more accurate and sophisticated data of how the new molecule affect the cell and predict its toxicity.
Artificial human tissues can provide that information and fill the gap between Pre-Clinical and Clinical phases of the whole Drug Development value chain.